BridgeMD
Compares treatment options for Carcinoma, Non-Small-Cell Lung
Official title ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
ClinicalTrials.gov ID: NCT03786003
What this study is testing
- What it's testing
- This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1007). The goal of this study is to determine video-assisted thoracoscopic surgery is non-inferior to thoracotomy in terms of disease-free survival for solid clinical stage T1N0M0 NSCLC.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Clinical stage T1N0M0 and surgical resectable.
- Solid appearance on computed tomography scan.
- Age 18 to 75 year.
- Signed the informed consent form.
You likely can't join if
- Not NSCLC in pathological analysis.
- Not lobectomy or sublobar resection.
- History of other malignant tumors within 5 years.
- History of thoracic surgery or unsuitable for VATS.
- Previous radiation or chemotherapy.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.